Eris Lifesciences reports receipt of a Regulation 74(5) compliance certificate for dematerialisation for the quarter ended 31 December 2025, confirming accepted/rejected dematerialised securities and listing alignment with existing exchanges.
AI Assistant
ERIS Lifesciences Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.